The Significance of Complex Karyotype in Multiple Myeloma

被引：0
|
作者：
Lalagianni, Chrysavgi [1 ]
Varelas, Christos [1 ]
Douka, Vasiliki [1 ]
Kyriakou, Ioannis [1 ]
Dadaki, Eirini [1 ]
Tzatzanis, Raphail [1 ]
Bountoura, Stephania [1 ]
Iskas, Michail [1 ]
Papathanasiou, Maria [1 ]
Papaioannou, George [1 ]
Athanasiadou, Anastasia [1 ]
Sakellari, Ioanna [1 ]
机构：
[1] George Papanikolaou Hosp, London, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-227
引用
收藏
页码：S168 / S169
页数：2
相关论文
共 50 条
  • [1] Characterization of the Karyotype in Patients with Multiple Myeloma by the Combination of Karyotype Analysis, FISH and CGH
    Busert, Barbara
    Schwanitz, Gesa
    Schubert, Regine
    Gamerdinger, Ulrike
    Schmidt-Wolf, Ingo G. H.
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2010, 10 (04) : 217 - 222
  • [2] Elevated endonuclease activity with complex karyotype in myeloma.
    Shammas, MA
    Wang, JY
    Batchu, RB
    Shah, S
    Wang, Y
    Rosen, NA
    Freeman, J
    Munshi, NC
    BLOOD, 2000, 96 (11) : 752A - 752A
  • [3] PLASMA-CELL KARYOTYPE IN MULTIPLE-MYELOMA
    GOULD, J
    ALEXANIAN, R
    GOODACRE, A
    PATHAK, S
    HECHT, B
    BARLOGIE, B
    BLOOD, 1988, 71 (02) : 453 - 456
  • [4] Correlations between karyotype and cytologic findings in multiple myeloma
    Weh, HJ
    Bartl, R
    Seeger, D
    Selbach, J
    Kuse, R
    Hossfeld, DK
    LEUKEMIA, 1995, 9 (12) : 2119 - 2122
  • [5] Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma
    Uryu, Hideki
    Mishima, Yuko
    Ishihara, Yuko
    Shirouchi, Yuko
    Yamauchi, Nobuhiko
    Hirano, Mitsuhito
    Hirano, Kei
    Teramoto, Yukako
    Yoshida, Kikuaki
    Maruyama, Dai
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (01) : 10 - 20
  • [6] NONRANDOM KARYOTYPE ABNORMALITIES IN 36 MULTIPLE-MYELOMA PATIENTS
    ANKATHIL, R
    MADHAVAN, J
    GANGADHARAN, VP
    PILLAI, GR
    NAIR, MK
    CANCER GENETICS AND CYTOGENETICS, 1995, 83 (01) : 71 - 74
  • [7] KARYOTYPE IN MULTIPLE-MYELOMA AND PLASMA-CELL LEUKEMIA
    WEH, HJ
    GUTENSOHN, K
    SELBACH, J
    KRUSE, R
    WACKERBACKHAUS, G
    SEEGER, D
    FIEDLER, W
    FETT, W
    HOSSFELD, DK
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) : 1269 - 1273
  • [8] Suppression of abnormal karyotype predicts superior survival in multiple myeloma
    V Arzoumanian
    A Hoering
    J Sawyer
    F van Rhee
    C Bailey
    J Gurley
    J D Shaughnessy
    E Anaissie
    J Crowley
    B Barlogie
    Leukemia, 2008, 22 : 850 - 855
  • [9] FAMILIAL MULTIPLE MYELOMA - IMMUNOLOGIC AND KARYOTYPE STUDY OF ONE CASE
    MANIGAND, G
    SARRAZIN, A
    DEMUTH, L
    SCHOEN, E
    DEPARIS, M
    ROPARTZ, C
    RIVAT, L
    PRESSE MEDICALE, 1970, 78 (40): : 1741 - &
  • [10] Suppression of abnormal karyotype predicts superior survival in multiple myeloma
    Arzoumanian, V.
    Hoering, A.
    Sawyer, J.
    van Rhee, F.
    Bailey, C.
    Gurley, J.
    Shaughnessy, J. D., Jr.
    Anaissie, E.
    Crowley, J.
    Barlogie, B.
    LEUKEMIA, 2008, 22 (04) : 850 - 855
12345